Applied DNA Achieves Program Milestone in Development of Linear DNA Veterinary COVID-19 Vaccine
February 2nd, 2021
Tag: Evvivax
APDN, Evvivax and GVS Receive Approval for Veterinary COVID-19 Clinical Trial
November 30th, 2020
Veterinary COVID-19 Vaccine Clinical Trial
September 16th, 2020
LineaRx and Takis/Evvivax Anti-Cancer Vaccine Candidates Demonstrate Tumor Reduction
September 19th, 2019
Applied DNA Subsidiary LineaRx and Takis/Evvivax Progress Linear DNA for Use as Cancer Vaccine Candidates
March 1st, 2019
LineaRx agreement with Takis and Evvivax for cancer vaccines
September 21st, 2018
Pharmaceutical Technology | LineaRx signs drug development agreement with Takis
September 21st, 2018
LineaRx to Collaborate with Takis and Evvivax on Cancer Vaccines
September 20th, 2018
Applied DNA Subsidiary, LineaRx, Inc. Signs Joint Development Agreement with Takis and Evvivax to Develop Linear-DNA Based Anti-Cancer Vaccines
September 20th, 2018